Related Experiment Video
Updated: May 14, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
ASBEL, an ANA/BTG3 antisense transcript required for tumorigenicity of ovarian carcinoma
Satoshi Yanagida1, Kenzui Taniue, Hironobu Sugimasa
1Laboratory of Molecular and Genetic Information, Institute of Molecular and Cellular Biosciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan.
Abstract:
Mammalian genomes encode numerous antisense non-coding RNAs, which are assumed to be involved in the regulation of the sense gene expression. However, the mechanisms of their action and involvement in the development of diseases have not been well elucidated. The ANA/BTG3 protein is an antiproliferative protein whose expression is downregulated in prostate and lung cancers. Here we show that an antisense transcript of the ANA/BTG3 gene, termed ASBEL, negatively regulates the levels of ANA/BTG3 protein, but not of ANA/BTG3 mRNA and is required for proliferation and tumorigenicity of ovarian clear cell carcinoma. We further show that knockdown of ANA/BTG3 rescues growth inhibition caused by ASBEL knockdown. Moreover, we demonstrate that ASBEL forms duplexes with ANA/BTG3 mRNA in the nucleus and suppresses its cytoplasmic transportation. Our findings illustrate a novel function for an antisense transcript that critically promotes tumorigenesis by suppressing translation of the sense gene by inhibiting its cytoplasmic transportation.
Insights
Antisense RNA ASBEL promotes ovarian cancer by blocking ANA/BTG3 protein transport. Reducing ASBEL inhibits tumor growth, revealing a new mechanism in cancer development.
Area of Science:
- Molecular biology
- Genomics
- Cancer research
Background:
- Antisense non-coding RNAs regulate gene expression, but their mechanisms and disease links are unclear.
- ANA/BTG3 protein, an antiproliferative factor, is downregulated in cancers.
- Ovarian clear cell carcinoma (OCCC) is a significant gynecological malignancy.
Purpose of the Study:
- To investigate the role of the ANA/BTG3 antisense transcript (ASBEL) in OCCC.
- To elucidate the mechanism by which ASBEL affects ANA/BTG3 expression and function.
- To determine ASBEL's contribution to cancer proliferation and tumorigenicity.
Main Methods:
- Gene knockdown experiments (ASBEL and ANA/BTG3).
- Analysis of protein and mRNA levels.
- Cellular localization studies (nuclear and cytoplasmic transport).
- Assessment of cell proliferation and tumorigenicity.
Main Results:
- ASBEL negatively regulates ANA/BTG3 protein levels, not mRNA.
- ASBEL is essential for OCCC proliferation and tumorigenicity.
- ASBEL forms nuclear duplexes with ANA/BTG3 mRNA, inhibiting its cytoplasmic transport.
- Knockdown of ANA/BTG3 rescues growth inhibition caused by ASBEL knockdown.
Conclusions:
- ASBEL promotes tumorigenesis by inhibiting ANA/BTG3 mRNA translation via suppressed cytoplasmic transport.
- This study reveals a novel mechanism of antisense transcript function in cancer development.
- Targeting ASBEL may offer a therapeutic strategy for OCCC.
Related Concept Videos
Experimental RNAi
MicroRNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
